2014
Dialysis versus Nondialysis in Patients with AKI: A Propensity-Matched Cohort Study
Wilson FP, Yang W, Machado CA, Mariani LH, Borovskiy Y, Berns JS, Feldman HI. Dialysis versus Nondialysis in Patients with AKI: A Propensity-Matched Cohort Study. Clinical Journal Of The American Society Of Nephrology 2014, 9: 673-681. PMID: 24651073, PMCID: PMC3974360, DOI: 10.2215/cjn.07630713.Peer-Reviewed Original ResearchMeSH KeywordsAcute Kidney InjuryAdultAgedBiomarkersCreatinineFemaleHospitalizationHumansKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioPatient SelectionPennsylvaniaPropensity ScoreProportional Hazards ModelsRenal DialysisRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsTreatment OutcomeConceptsInitiation of dialysisSerum creatinine concentrationCreatinine concentrationDialysis initiationDialyzed patientsSevere AKICohort studyPropensity-matched cohort studyPropensity scoreElevated creatinine levelOverall hazard ratioGreater survival benefitProportional hazards analysisAcute care hospitalsTime-varying propensity scoresPennsylvania Health SystemCause mortalityCreatinine levelsHazard ratioSurvival benefitCare hospitalDL increaseNondialyzed patientsPatient factorsLaboratory variables
2012
Predictors of Death and Dialysis in Severe AKI: The UPHS-AKI Cohort
Wilson FP, Yang W, Feldman HI. Predictors of Death and Dialysis in Severe AKI: The UPHS-AKI Cohort. Clinical Journal Of The American Society Of Nephrology 2012, 8: 527-537. PMID: 23258795, PMCID: PMC3613955, DOI: 10.2215/cjn.06450612.Peer-Reviewed Original ResearchConceptsSevere AKIC-indexIntensive care unit locationPredictors of deathEffective risk stratificationEndpoint of deathMore effective therapeutic interventionsHigh-risk subgroupsHarrell's C-indexLower overall mortalityProportional hazards modelEffective therapeutic interventionsPennsylvania Health SystemBaseline creatinineHospital AKIPressor medicationsSerum creatinineClinical factorsDerivation cohortHigher creatinineHospital admissionOverall mortalityLiver diseaseRisk stratificationValidation cohort